uniQure (NASDAQ: QURE)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-07-25 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.930 | -1.000 | -0.0700 | ||||
REV | 19.220M | 1.792M | -17.428M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of uniQure (NASDAQ: QURE) through any online brokerage.
There are no as such competitors for uniQure.
The latest price target for uniQure (NASDAQ: QURE) was reported by Goldman Sachs on Tuesday, May 24, 2022. The analyst firm set a price target for 51.00 expecting QURE to rise to within 12 months (a possible 168.56% upside). 7 analyst firms have reported ratings in the last year.
The stock price for uniQure (NASDAQ: QURE) is $18.99 last updated Today at June 27, 2022, 6:43 PM UTC.
There are no upcoming dividends for uniQure.
uniQure’s Q2 earnings are confirmed for Monday, July 25, 2022.
There is no upcoming split for uniQure.
uniQure is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.